Author

Frederique Ponchel

The University of Leeds (LIRMM, TRIMID) - Cited by 6,474 - rheumatoid arthritis - autoimmune diseases

Biography

Dr. Frederique Ponchel, Currently working in The Leeds Trust Teaching Hospital, Studied in The University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK, Research interests are Rheumatoid Arthritis, Autoimmune Diseases
Title
Cited by
Year
Age-related changes in bone marrow mesenchymal stromal cells: a potential impact on osteoporosis and osteoarthritis development
P Ganguly, JJ El-Jawhari, PV Giannoudis, AN Burska, F Ponchel, ...Cell transplantation 26 (9), 1520-1529, 2017201
192
2017
The analysis of in vivo aging in human bone marrow mesenchymal stromal cells using colony-forming unit-fibroblast assay and the CD45lowCD271+ phenotype
P Ganguly, JJ El-Jawhari, AN Burska, F Ponchel, PV Giannoudis, ...Stem cells international 2019, 2019201
59
2019
Biomarkers of joint damage in osteoarthritis: current status and future directions
R Kumavat, V Kumar, R Malhotra, H Pandit, E Jones, F Ponchel, S BiswasMediators of Inflammation 2021, 2021202
42
2021
Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomes
HL Gul, G Eugenio, T Rabin, A Burska, R Parmar, J Wu, F Ponchel, ...Rheumatology 59 (3), 613-621, 2020202
30
2020
Differential CpG DNA methylation in peripheral naïve CD4+ T-cells in early rheumatoid arthritis patients
R Pitaksalee, AN Burska, S Ajaib, J Rogers, R Parmar, K Mydlova, X Xie, ...Clinical Epigenetics 12, 1-16, 2020202
22
2020
T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management
F Ponchel, AN Burska, L Hunt, H Gul, T Rabin, R Parmar, MH Buch, ...Scientific Reports 10 (1), 3669, 2020202
21
2020
The RA-MAP Consortium: a working model for academia–industry collaboration
AP Cope, MR Barnes, A Belson, M Binks, S Brockbank, ...Nature Reviews Rheumatology 14 (1), 53-60, 2018201
21
2018
Dynamics of early signalling events during fracture healing and potential serum biomarkers of fracture non-union in humans
AN Burska, PV Giannoudis, BH Tan, D Ilas, E Jones, F PonchelJournal of clinical medicine 9 (2), 492, 2020202
19
2020
Gene expression and functional comparison between multipotential stromal cells from lateral and medial condyles of knee osteoarthritis patients
C Sanjurjo-Rodriguez, TG Baboolal, AN Burska, F Ponchel, JJ El-Jawhari, ...Scientific Reports 9 (1), 9321, 2019201
16
2019
Effect of Fatigue, Older Age, Higher Body Mass Index, and Female Sex on Disability in Early Rheumatoid Arthritis in the Treatment‐to‐Target Era
S Twigg, EMA Hensor, J Freeston, AL Tan, P Emery, A Tennant, ...Arthritis care & research 70 (3), 361-368, 2018201
13
2018
Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis
AN Burska, A Thu, R Parmar, I Bzoma, B Samans, E Raschke, S Olek, ...Rheumatology 58 (11), 2015-2024, 2019201
12
2019
Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis
F Ponchel, MAM van Delft, X Xie, AN Burska, L Duquenne, LA Trouw, ...Clin Exp Rheumatol 39 (1), 146-150, 2021202
11
2021
Auto-antibodies to post-translationally modified proteins in osteoarthritis
X Xie, MAM van Delft, F Shuweihdi, SR Kingsbury, LA Trouw, GM Doody, ...Osteoarthritis and Cartilage 29 (6), 924-933, 2021202
11
2021
Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity
A Lamana, R Villares, IV Seoane, N Andrés, P Lucas, P Emery, EM Vital, ...Frontiers in Immunology 11, 1336, 2020202
8
2020
Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis
AN Burska, JJ El-Jawhari, J Wu, RJ Wakefield, H Marzo-Ortega, ...Clinical and Experimental Rheumatology 39 (3), 456-462, 2021202
8
2021
Serum IL-7 as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria
Serum IL- as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteriaAN Burska, J Neilan, RE Chisman, R Pitaksalee, R Hodgett, ...Clin. Exp. Rheumatol 36, 115-120, 2018201
7
2018
B‐cell capacity for differentiation changes with age
X Xie, J Shrimpton, GM Doody, PG Conaghan, F PonchelAging Cell 20 (4), e13341, 2021202
5
2021
Interferon-related gene expression in response to TNF inhibitor treatment in ankylosing spondylitis patients: a pilot study
SR Harrison, AN Burska, P Emery, H Marzo-Ortega, F PonchelRheumatology 60 (8), 3607-3616, 2021202
5
2021
RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients
Scientific data 9 (1), 196, 2022202
3
2022
OP0182 IN RA PATIENTS IN REMISSION, WHICH BIOMARKERS PREDICT SUCCESSFUL TAPERING OF CSDMARDS?
H Gul, F Ponchel, P EmeryAnnals of the Rheumatic Diseases 80 (Suppl 1), 110-110, 2021202
3
2021

Referred From: https://scholar.google.com/citations?user=ZeN1RwsAAAAJ

Cited by
Citations 6474
h-index 43
i10-index 68
Recommended Journals
Open Access Journals